Pfizer to sell green senior notes due 2031 via four bookrunners

By Devika Patel

Knoxville, Tenn., Aug. 16 – Pfizer Inc. plans to price green senior notes due 2031, according to a 424B3 filing with the Securities and Exchange Commission.

The notes will feature a make-whole call and then a par call.

Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are the bookrunners.

Proceeds will be used for eligible green projects, including research for global public health emergencies, such as the Covid-19 pandemic.

Pfizer is a biopharmaceutical company based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.